Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages.
作者： Kezhong Tang , Wenjie Lu , Wenjie Qin , Yulian Wu
DOI: 10.1016/J.PAN.2015.11.007
关键词:
摘要: … staged borderline resectable pancreatic cancer. To refine the … , and those with the following design: neoadjuvant therapy … identical patient cohorts, and those available only in abstract …
pancreatology.net 参考文章(39)
O. Strobel, M.W. Büchler, Borderline-Resektabilität beim Pankreaskarzinom: Konsensus-Statement der ISGPS Chirurg. ,vol. 85, pp. 1014- 1014 ,(2014) , 10.1007/S00104-014-2902-Z
Bonciarelli G, Polistina F, Frego M, Di Natale G, Ambrosino G, Neoadjuvant strategies for pancreatic cancer World Journal of Gastroenterology. ,vol. 20, pp. 9374- 9383 ,(2014) , 10.3748/WJG.V20.I28.9374
Brian A. Boone, Jennifer Steve, Alyssa M. Krasinskas, Amer H. Zureikat, Barry C. Lembersky, Michael K. Gibson, Ronald G. Stoller, Herbert J. Zeh, Nathan Bahary, Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer Journal of Surgical Oncology. ,vol. 108, pp. 236- 241 ,(2013) , 10.1002/JSO.23392
Francesco Leone, Marco Gatti, Paolo Massucco, Federica Colombi, Elisa Sperti, Delia Campanella, Daniele Regge, Pietro Gabriele, Lorenzo Capussotti, Massimo Aglietta, Induction gemcitabine and oxaliplatin therapy followed by a twice-weekly infusion of gemcitabine and concurrent external-beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer: a single institutional experience. Cancer. ,vol. 119, pp. 277- 284 ,(2013) , 10.1002/CNCR.27736
Angelo Andriulli, Virginia Festa, Edoardo Botteri, Maria R. Valvano, Maurizio Koch, Claudio Bassi, Patrick Maisonneuve, Pierluigi Di Sebastiano, Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies Annals of Surgical Oncology. ,vol. 19, pp. 1644- 1662 ,(2012) , 10.1245/S10434-011-2110-8
J. Bart Rose, Flavio G. Rocha, Adnan Alseidi, Thomas Biehl, Ravi Moonka, John A. Ryan, Bruce Lin, Vincent Picozzi, Scott Helton, Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival Annals of Surgical Oncology. ,vol. 21, pp. 1530- 1537 ,(2014) , 10.1245/S10434-014-3486-Z
CP Xu, XJ Xue, N Liang, DG Xu, FJ Liu, XS Yu, JD Zhang, None, Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. ,vol. 140, pp. 549- 559 ,(2014) , 10.1007/S00432-013-1572-4
Rebecca J. McClaine, Andrew M. Lowy, Jeffrey J. Sussman, Nathan Schmulewitz, David L. Grisell, Syed A. Ahmad, Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer Hpb. ,vol. 12, pp. 73- 79 ,(2010) , 10.1111/J.1477-2574.2009.00136.X
Matthew H. G. Katz, Jason B. Fleming, Priya Bhosale, Gauri Varadhachary, Jeffrey E. Lee, Robert Wolff, Huamin Wang, James Abbruzzese, Peter W. T. Pisters, Jean-Nicolas Vauthey, Chusilp Charnsangavej, Eric Tamm, Christopher H. Crane, Aparna Balachandran, Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators Cancer. ,vol. 118, pp. 5749- 5756 ,(2012) , 10.1002/CNCR.27636
Nicole E Lopez, Cristina Prendergast, Andrew M Lowy, Borderline resectable pancreatic cancer: Definitions and management World Journal of Gastroenterology. ,vol. 20, pp. 10740- 10751 ,(2014) , 10.3748/WJG.V20.I31.10740